LivaNova announces first patient implanted in OSPREY clinical study
Study to evaluate effectiveness of hypoglossal nerve stimulation
Study to evaluate effectiveness of hypoglossal nerve stimulation
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
AROC3-1001 is a phase 1/2, placebo controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-C3
UCB plans to submit regulatory applications in Q3 2022
An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv
The study will be published on the pre-print server, medRXiv, shortly
Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
The first pilot study from India analyzing Covaxin-Covishield mixed doses
Subscribe To Our Newsletter & Stay Updated